Gavi, the Vaccine Alliance

What it reported doing in 2024

The vaccine goal: introduce and scale up vaccinesin 2024, lower-income countries protected more people, against more diseases, than any year in history.- 58 gavi-supported vaccine introductions and preventive campaigns took place in 2024 in addition to 50 outbreak response vaccination campaigns supported by gavi.- 32.6 million girls fully immunized against hpv with gavi support in 2024 alone more than the previous ten years combined.- 17 countries accessed cholera, meningococcal and yellow fever vaccines through gavi-supported emergency stockpiles a total of 44 times in 2024.- 57 gavi-supported countries increased breadth of protection with vaccines in the gavi portfolio to 63%, up 8 percentage points from 2023.the equity goal: strengthen health systems to increase equity in immunizationin gavi 5.0/5.1, health system strengthening (hss) support prioritizes equity in immunisation delivery, to reduce the number of zero-dose and under-immunized children.- >72 million children were reached with gavi-supported routine vaccines in 2024 more than in any year previously.- 48 countries have installed more than 64,000 cold chain equipment (cce) units procured by unicef supply division through gavi's cold chain equipment optimization platform (cceop) nearly 2,700 in 2024 alone.- average coverage of dtp3 in 26 low-income countries supported by gavi is not yet back to pre-pandemic levels (i.e. 75% in 2019) while lower-income countries exceeded 2019 coverage by 1 pp, reaching 87% in 2024.- in 2024, gavi-supported countries increased dtp3 coverage at 82% (compared to the 85% global average).the sustainability goal: improve sustainability of immunization programs2024 was another record-breaking year for co-financing: even countries facing significant challenges increased their commitment to immunization.- us $255 million was contributed by countries towards the co-financing of gavi-supported vaccines in 2024 the highest amount yet and a testament to country ownership and the long-term financial sustainability of gavi-supported vaccines.- 55 vaccine programs originally introduced with gavi funding are now self-financed by countries as of 2023, up from 40 in 2018.- 100% of countries fully met their 2024 co-financing obligation except six waivers for humanitarian crisis.- in the face of fiscal challenges, climate change, conflict and instability, most gavi-supported countries maintained or increased domestic resources for co-financing of gavi-supported vaccines in 2024, bringing to us $1.9 billion their total contribution since the introduction of the co-financing policy in 2008.the healthy markets goal: ensure healthy markets for vaccines and related productsgavi's market shaping efforts make life-saving vaccines and other immunisation products more accessible and affordable for lower-income countries.- 10 markets for vaccines and immunisation products exhibited acceptable levels of healthy market dynamics in 2024, meeting the target for the year.- 12 innovative products were within the pipeline of commercial-scale manufacturers in 2024, continuing to exceed the alliance target of 8 by 2025 well ahead of schedule.- 500,000 mpox vaccine doses within a month of the who emergency declaration.- through gavi's market shaping efforts, the number of manufacturers supplying prequalified gavi-supported vaccines remained at 20 in 2024 (with more than half based in low- and middle-income countries) compared with 5 in 2001.further information on gavi's progress towards achieving its strategic goals can be found in its 2024 annual progress report, online at: https://www.gavi.org/programmes-impact/our-impact/progress-reports.

Financial Efficiency

• Mission deployment rate: 100%; rating input score 100
• Program expense ratio: 97%; rating input score 97
• Fundraising efficiency: $54.85 raised per $1 spent on fundraising; rating input score 76; 76th percentile among comparable filings

Transparency & Controls

• Consistency checks: 100%; rating input score 100; 68th percentile among comparable filings
• Pay-setting controls: 3 of 6 controls in place; rating input score 50
  • Compensation committee: Missing
  • Independent consultant: Pass
  • Other Form 990s reviewed: Missing
  • Written employment contract: Missing
  • Compensation survey or study: Pass
  • Board or committee approval: Pass
• Foreign activity oversight: 4 of 8 controls in place; rating input score 50
  • Claims monitoring procedures: Pass
  • Requires narrative reports: Fail
  • Conducts field audits: Pass
  • May suspend future funding: Fail
  • Requires financial reports: Pass
  • Conducts site visits: Fail
  • Requires grant agreements: Pass
  • May require repayment: Fail
• Grant itemization coverage: 100%; rating input score 100; 54th percentile among comparable filings
• Major donor itemization: Yes; rating input score 100
• Related-party transparency: Yes; rating input score 100

Accountability

• Independent voting board: 100%; rating input score 100; 77th percentile among comparable filings
• Governance controls: 8 of 9 controls in place; rating input score 89
  • Conflict-of-interest policy: Pass
  • Whistleblower policy: Pass
  • Document-retention policy: Pass
  • CEO compensation review process: Pass
  • Other executive compensation review process: Pass
  • Form 990 shared with the board: Fail
  • Board meeting minutes documented: Pass
  • Audit committee oversight: Pass
  • Independent financial-statement audit: Pass

Sustainability

• Operating margin: -22.2%; rating input score 3; 3rd percentile among comparable filings
• Total-asset coverage ratio: 3.05; rating input score 76; 76th percentile among comparable filings
• Liabilities to assets ratio: 0.25; rating input score 62; 62nd percentile among comparable filings
• Officer compensation ratio: 0.2%; rating input score 91; 91st percentile among comparable filings

Growth

• Program expense growth: -6.1% per year; rating input score 0; 2nd percentile among comparable filings
• Revenue growth: -23.6% per year; rating input score 0; 0th percentile among comparable filings
• Asset growth: -0.7% per year; rating input score 0; 6th percentile among comparable filings